West Pharmaceutical Services Inc
WST248.950USD
+17.500+7.56%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
17.90BMarket Cap
36.66P/E TTM
More Details of West Pharmaceutical Services Inc Company
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
West Pharmaceutical Services Inc Info
Ticker SymbolWST
Company nameWest Pharmaceutical Services Inc
IPO dateSep 01, 2059
CEOGreen (Eric Mark)
Number of employees10600
Security typeOrdinary Share
Fiscal year-endSep 01
Address530 Herman O. West Drive
CityEXTON
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code19341
Phone16105942900
Websitehttps://www.westpharma.com/
Ticker SymbolWST
IPO dateSep 01, 2059
CEOGreen (Eric Mark)
Company Executives of West Pharmaceutical Services Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
171.12K
+2668.00%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
44.97K
+1071.00%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
42.94K
+1071.00%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
42.80K
+1071.00%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
21.84K
+920.00%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.01K
+1071.00%
Mr. Paolo Pucci
Mr. Paolo Pucci
Independent Director
Independent Director
10.46K
+1071.00%
Mr. Robert F. (Rob) Friel
Mr. Robert F. (Rob) Friel
Lead Independent Director
Lead Independent Director
4.14K
+1071.00%
Dr. Stephen H. Lockhart, M.D., Ph.D.
Dr. Stephen H. Lockhart, M.D., Ph.D.
Independent Director
Independent Director
2.16K
+1071.00%
Ms. Janet Brutschea Haugen
Ms. Janet Brutschea Haugen
Independent Director
Independent Director
1.56K
+1071.00%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
171.12K
+2668.00%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
44.97K
+1071.00%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
42.94K
+1071.00%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
42.80K
+1071.00%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
21.84K
+920.00%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.01K
+1071.00%
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
High Value Components
386.21M
48.00%
Contract-Manufactured Products
160.92M
20.00%
Standard Packaging
160.92M
20.00%
Delivery Devices
96.55M
12.00%
By RegionUSD
Name
Revenue
Proportion
Americas
378.16M
47.00%
Europe Middle East and Africa
362.07M
45.00%
Asia Pacific
64.36M
8.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
High Value Components
386.21M
48.00%
Contract-Manufactured Products
160.92M
20.00%
Standard Packaging
160.92M
20.00%
Delivery Devices
96.55M
12.00%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
13.21%
BlackRock Institutional Trust Company, N.A.
5.27%
State Street Investment Management (US)
4.46%
Artisan Partners Limited Partnership
3.85%
Brown Advisory
3.47%
Other
69.73%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
13.21%
BlackRock Institutional Trust Company, N.A.
5.27%
State Street Investment Management (US)
4.46%
Artisan Partners Limited Partnership
3.85%
Brown Advisory
3.47%
Other
69.73%
Shareholder Types
Shareholders
Proportion
Investment Advisor
47.81%
Investment Advisor/Hedge Fund
32.29%
Hedge Fund
6.89%
Pension Fund
4.16%
Research Firm
2.24%
Bank and Trust
1.71%
Sovereign Wealth Fund
1.37%
Insurance Company
0.76%
Endowment Fund
0.62%
Other
2.16%
Institutional Shareholding
Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
1307
70.33M
100.32%
--
2025Q4
1647
70.50M
97.99%
-4.08M
2025Q3
1640
70.77M
98.37%
-2.34M
2025Q2
1636
72.03M
100.16%
-1.82M
2025Q1
1662
71.25M
99.16%
-2.66M
2024Q4
1626
70.93M
98.10%
-2.28M
2024Q3
1603
70.42M
97.07%
-3.49M
2024Q2
1609
70.03M
96.14%
-3.89M
2024Q1
1617
70.47M
96.25%
-3.65M
2023Q4
1622
70.59M
95.41%
-3.14M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
9.67M
13.44%
+388.14K
+4.18%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.79M
5.27%
+6.71K
+0.18%
Sep 30, 2025
State Street Investment Management (US)
3.21M
4.46%
-63.95K
-1.95%
Sep 30, 2025
Artisan Partners Limited Partnership
2.77M
3.85%
+503.60K
+22.21%
Sep 30, 2025
Brown Advisory
2.50M
3.47%
-523.20K
-17.32%
Sep 30, 2025
Walter Scott & Partners Ltd.
1.93M
2.69%
-267.71K
-12.17%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.86M
2.58%
+24.12K
+1.32%
Sep 30, 2025
Van Eck Associates Corporation
1.42M
1.98%
-61.31K
-4.13%
Sep 30, 2025
APG Asset Management N.V.
1.41M
1.97%
-244.97K
-14.77%
Sep 30, 2025
Durable Capital Partners LP
1.17M
1.63%
+131.94K
+12.68%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Motley Fool Mid-Cap Growth ETF
3.52%
VanEck Morningstar Wide Moat ETF
2.83%
First Trust Indxx Medical Devices ETF
2.15%
VanEck Morningstar Wide Moat Value ETF
2.14%
Invesco S&P 500 Equal Weight Health Care ETF
1.8%
Nuveen ESG Mid-Cap Growth ETF
1.72%
American Century Mid Cap Growth Impact ETF
1.63%
Hilton Small-MidCap Opportunity ETF
1.51%
iShares Health Innovation Active ETF
1.5%
ProShares S&P 500 Dividend Aristocrats ETF
1.46%
View more
Motley Fool Mid-Cap Growth ETF
Proportion3.52%
VanEck Morningstar Wide Moat ETF
Proportion2.83%
First Trust Indxx Medical Devices ETF
Proportion2.15%
VanEck Morningstar Wide Moat Value ETF
Proportion2.14%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion1.8%
Nuveen ESG Mid-Cap Growth ETF
Proportion1.72%
American Century Mid Cap Growth Impact ETF
Proportion1.63%
Hilton Small-MidCap Opportunity ETF
Proportion1.51%
iShares Health Innovation Active ETF
Proportion1.5%
ProShares S&P 500 Dividend Aristocrats ETF
Proportion1.46%
Dividend
A total of
221.30M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Dec 10, 2025
WST.NB Interim Cash Dividend of gross USD 0.22 paid on Feb 04, 2026 going ex on Jan 28, 2026
Jan 28, 2026
Feb 04, 2026
Jan 28, 2026
Jul 24, 2025
WST.NB Final Cash Dividend of gross USD 0.22 paid on Nov 19, 2025 going ex on Nov 12, 2025
Nov 12, 2025
Nov 19, 2025
Nov 12, 2025
Apr 24, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on Aug 06, 2025 going ex on Jul 30, 2025
Jul 30, 2025
Aug 06, 2025
Jul 30, 2025
Feb 20, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on May 07, 2025 going ex on Apr 30, 2025
Apr 30, 2025
May 07, 2025
Apr 30, 2025
Jan 28, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on Feb 11, 2025 going ex on Feb 07, 2025
Feb 07, 2025
Feb 11, 2025
Feb 07, 2025
Oct 24, 2024
WST.NB Final Cash Dividend of gross USD 0.21 paid on Nov 20, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 20, 2024
Nov 13, 2024
Apr 25, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Aug 07, 2024 going ex on Jul 31, 2024
Jul 31, 2024
Aug 07, 2024
Jul 31, 2024
Feb 20, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on May 01, 2024 going ex on Apr 23, 2024
Apr 24, 2024
May 01, 2024
Apr 23, 2024
Dec 06, 2023
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 07, 2024 going ex on Jan 30, 2024
Jan 31, 2024
Feb 07, 2024
Jan 30, 2024
Oct 26, 2023
WST.NB Final Cash Dividend of gross USD 0.2 paid on Nov 15, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 15, 2023
Nov 07, 2023
View more
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
